1. Signaling Pathways
  2. Apoptosis
  3. Photosensitizer

Photosensitizer

Photosensitizers are light absorbers that alter the course of a photochemical reaction. They usually are catalysts. Photosensitizers have been used as light-responsive drugs with their imaging capabilities, easy synthesis, tunable energy levels, and biocompatibility, which make them an innovative tool for therapeutic approaches in treatment of various cancers. Among different methods for cancer therapy, photodynamic therapy (PDT) using a photosensitizer can take advantage of penetrated light into a targeted tissue for improving tumor control. The PDT comprises of three major components; photosensitizer, oxygen, and light source of appropriate wavelength, which when act together, generate a photochemical reaction. Depending on the part of the body being treated, the photosensitizing agent is either administered into the bloodstream through a vein or placed directly on the skin. By irradiation light on the targeted area, the excited photosensitizer emits energy in the form of heat and exhibits intersystem crossing (ISC), leading to the formation of reactive oxygen species (ROS) in triplet state.
Photosensitizers can function by many mechanisms, sometimes they donate an electron to the substrate, sometimes they abstract a hydrogen atom from the substrate. At the end of this process, the photosensitizer returns to its ground state, where it remains chemically intact, poised to absorb more light. One branch of chemistry which frequently utilizes photosensitizers is polymer chemistry, using photosensitizers in reactions such as photopolymerization, photocrosslinking, and photodegradation. Photosensitizers are also used to generate prolonged excited electronic states in organic molecules with uses in photocatalysis, photon upconversion and photodynamic therapy. Generally, photosensitizers absorb electromagnetic radiation consisting of infrared radiation, visible light radiation, and ultraviolet radiation and transfer absorbed energy into neighboring molecules[1][2].

Photosensitizer Related Products (54):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-19873
    SL-052
    SL-052 is a hypocrellin-based photosensitizer that has recently shown promising results in clinical and preclinical testing for cancer photodynamic therapy (PDT). SL-052 is encapsulated in biodegradable polylactic-co-glycolic acid (PLGA) polymer nanoparticles optimized using single emulsion solvent evaporation technology. The SL-052-PLGA nanoparticles were more effective in PDT treatment of subcutaneous SCCVII squamous cell carcinoma compared to polyvinylpyrrolidone (PVP)-based and standard liposomal SL-052 formulations. A longer time interval between drug injection and tumor illumination can improve tumor cure rates, and SL-052-PLGA nanoparticles showed the best therapeutic effect among all SL-052 formulations.
    SL-052
  • HY-126841
    5-Methoxysterigmatocystin
    5-Methoxysterigmatocystin is a mycotoxin with cytotoxic and genotoxic properties. 5-Methoxysterigmatocystin exhibits cytotoxicity against cancer cells A549 and HepG2 (IC50 of 5.5 and 0.7 μM), and induces DNA damage. 5-Methoxysterigmatocystin is a photosensitizer, which utilizes the visible to generate singlet oxygen (1O2).
    5-Methoxysterigmatocystin
  • HY-Y1129S
    3-Hydroxypyridine-d4
    3-Hydroxypyridine-d4 is the deuterium labeled 3-Hydroxypyridine (HY-Y1129). 3-Hydroxypyridine is a compound that can be isolated from bamboo grass. As an endogenous photosensitizer present in human skin, 3-hydroxypyridine can mediate oxidative stress, proliferation inhibition and apoptosis of skin cells through UVA/UVB excitation.
    3-Hydroxypyridine-d<sub>4</sub>
  • HY-137474
    Purpurin 18 methyl ester
    Purpurin 18 methyl ester, a chlorophyll-a derivative, is a photosensitizer that can be used in photodynamic therapy (PDT). Purpurin 18 methyl ester has photodynamic activity to induce cancer cell death.
    Purpurin 18 methyl ester
  • HY-143617
    photoCORM-1
    photoCORM-1 (compound 8) is a combinatorial carbon monoxide releasing molecule (CORM). photoCORM-1 exhibits good cellular uptake and real-time monitoring ability of CO uncaging by a color change approach. photoCORM-1 has anti-tumor antivity.
    photoCORM-1
  • HY-170490
    TTQ-SA
    TTQ-SA is a near-infrared (NIR) spiro-AIEgen (aggregation-induced emission luminogen), that converts near-infrared light (NIR) into thermal energy, causing thermal damage and death of tumor cells. TTQ-SA exhibits cellular uptake and targeting ability in cancer cell MF-7. TTQ-SA silences the expression of survivin gene with combination of DNAzyme, enhances the sensitivity of tumor cells to photothermal therapy.
    TTQ-SA
  • HY-164294
    Aluminum phthalocyanine disulfonate
    Aluminum phthalocyanine disulfonate is a potential photosensitizer used for the research of Sonodynamic therapy (SDT).
    Aluminum phthalocyanine disulfonate
  • HY-16477A
    Talaporfin
    Talaporfin sodium, can be used in intraoperative photodynamic therapy (PDT) with a 664-nm semiconductor laser, was evaluated for efficacy and safety in treating primary malignant parenchymal brain tumors.
    Talaporfin
  • HY-Y0546S2
    Benzophenone-13C
    Benzophenone-13C is the 13C labeled Benzophenone (HY-Y0546). Benzophenone is an endogenous metabolite. Benzophenone is a photosensitizer, that absorbs UV light, transfers its energy to DNA, and triggers DNA damage. Benzophenone can be used as the fragrance enhancer, ultraviolet curing agent, additive in plastics, or the flavor ingredient. Benzophenone can also be used in the manufacturing of insecticides, agricultural chemicals, hypnotics, antihistamines, and other pharmaceuticals. Benzophenone exhibits certain carcinogenicity in mouse/rat models under long term exposure. Benzophenone exhibits estrogenic activity.
    Benzophenone-<sup>13</sup>C
  • HY-146416
    Antitumor photosensitizer-2
    Antitumor photosensitizer-2 (Compound 11) is a potent photosensitizer. Antitumor photosensitizer-2 has outstanding photodynamic anti-tumor effects without obvious skin photo-toxicity, and can act as new agent candidates for photodynamic research.
    Antitumor photosensitizer-2
  • HY-162825
    Antitumor photosensitizer-7
    Antitumor photosensitizer-7 (compound 15) is a photosensitizer with anti-cancer activity. Antitumor photosensitizer-7 exhibits significant cytotoxicity against the G361 melanoma cell line under 414 nm blue light irradiation.
    Antitumor photosensitizer-7
  • HY-162129
    Antitumor agent-131
    Antitumor agent-131 (Compound 2-p) is an ER fluorescent probe with an IC50 value of 23 nM for HepG2 tumor cells. Antitumor agent-131 can be used as a photosensitizer for the study of cancer photodynamics.
    Antitumor agent-131
  • HY-141861
    Anticancer agent 17
    Anticancer agent 17 displays potent anticancer activities against HeLa and A2780 cells with IC50 values of 0.19 μM and 0.09 μM, respectively.
    Anticancer agent 17
  • HY-128419
    Biguanidinium-porphyrin
    Biguanidinium-porphyrin is a mitochondria-targeting photosensitizer. Biguanidinium-porphyrin distributes within cell membranes with a large component in vesicles that correlated to some extent with the lysosomes and, upon longer exposures, in mitochondria and the cytosolic membrane.
    Biguanidinium-porphyrin
  • HY-146414
    Antitumor photosensitizer-1
    Antitumor photosensitizer-1 (Compound 8) is a potent photosensitizer. Antitumor photosensitizer-1 has outstanding photodynamic anti-tumor effects without obvious skin photo-toxicity, and can act as new agent candidates for photodynamic research.
    Antitumor photosensitizer-1
  • HY-125600
    LY219703
    LY219703 is a photoactivatable analogue of the antitumor diarylsulfonylurea sulofenur. LY219703 are distributed mainly in membranes, particularly those of organelles such as mitochondria.
    LY219703
  • HY-168854
    TBC-1
    TBC-1 is a chlorophyll-a derivative, is a photosensitizer that can be used in photodynamic therapy (PDT). TBC-1 efficiently generats Type-I ROS and endoplasmic reticulum targeting ability. TBC-1 shows biocompatibility and PDT efficiency in vitro under both normoxia and hypoxia.
    TBC-1
  • HY-161341
    β-Glucuronidase responsive conjugate 1
    β-Glucuronidase responsive conjugate 1 (compound 3) is a well-balanced photosensitizer which has photodynamic activity. β-Glucuronidase responsive conjugate 1 inhibits T-24 cell viability and growth with an IC50 of 0.2 μM. β-Glucuronidase responsive conjugate 1 can used to study bladder cancers.
    β-Glucuronidase responsive conjugate 1
  • HY-W738979
    Silicon naphthalocyanine dichloride
    Silicon naphthalocyanine dichloride is a photosensitizer with potential anti-tumor activity. Silicon naphthalocyanine dichloride is used as a cancer-inhibiting compound in photodynamic therapy. Silicon naphthalocyanine dichloride can effectively absorb light energy of a specific wavelength, thereby generating oxygen free radicals that help destroy cancer cells. The biocompatibility of Silicon naphthalocyanine dichloride makes it show good prospects in medical applications.
    Silicon naphthalocyanine dichloride
  • HY-W769206
    Talaporfin-13C4,15N
    Talaporfin-13C4,15N (ME2906 (free acid)-13C4,15N) is the 13C- and 15N-labeled Talaporfin (HY-16477A). Talaporfin sodium, can be used in intraoperative photodynamic therapy (PDT) with a 664-nm semiconductor laser, was evaluated for efficacy and safety in treating primary malignant parenchymal brain tumors.
    Talaporfin-<sup>13</sup>C<sub>4</sub>,<sup>15</sup>N